cancer-immunotherapy

Documents about cancer-immunotherapy

• Accelerated Radio-Immunotherapy for Lung Cancer#683086ClinicalTrials.gov
• Rituximab + Immunotherapy in Follicular Lymphoma#67886ClinicalTrials.gov
• GI Complications in Cancer Immunotherapy Patients#154634ClinicalTrials.gov
• Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy#174881ClinicalTrials.gov
• Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W#481749ClinicalTrials.gov
• Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.#387141ClinicalTrials.gov
• Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer#174892ClinicalTrials.gov
• T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers#172296ClinicalTrials.gov
• Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG#390924ClinicalTrials.gov
• Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology#266487Europe PMC
• Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.#329528ClinicalTrials.gov
• Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer#862508ClinicalTrials.gov
• Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L#141111ClinicalTrials.gov
• Study of Chemo-Immunotherapy in Head and Neck Cancer Patients#249583ClinicalTrials.gov
• PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer#268019ClinicalTrials.gov
• Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line#321691ClinicalTrials.gov
• Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer#353276ClinicalTrials.gov
• Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer#366594ClinicalTrials.gov
• An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).#405148ClinicalTrials.gov
• Physical Activity and Exercise in Cancer Immunotherapy Treatment#424191ClinicalTrials.gov
• Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer#444879ClinicalTrials.gov
• Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients#640576ClinicalTrials.gov
• Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy.#645305NCBI PubMed Central
• Mechanism of Cancer Induced Neutrophil Differentiation#672811UR Research
• QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA#146479ClinicalTrials.gov
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers#356487ClinicalTrials.gov
• Proteome-based Immunotherapy of Lung Cancer Brain Metastases#160154ClinicalTrials.gov
• NADIM II: Neo-Adjuvant Immunotherapy#283051ClinicalTrials.gov
• Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors#300240ClinicalTrials.gov
• Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients#18603ClinicalTrials.gov
• Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer#162458ClinicalTrials.gov
• NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial#180386ClinicalTrials.gov
• Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer#217041ClinicalTrials.gov
• National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer#329506ClinicalTrials.gov
• Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients#444880ClinicalTrials.gov
• Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer#448270ClinicalTrials.gov
• Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)#143545ClinicalTrials.gov
• T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy#154647ClinicalTrials.gov
• A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis#854031ClinicalTrials.gov
• Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours#854029ClinicalTrials.gov
• Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial#28327ClinicalTrials.gov
• Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies#279506ClinicalTrials.gov
• Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance#123477ClinicalTrials.gov
• Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC#230401ClinicalTrials.gov
• Plasmodium Immunotherapy for Breast and Liver Cancers#253014ClinicalTrials.gov
• Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer#283032ClinicalTrials.gov
• Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer#283044ClinicalTrials.gov
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer#287547ClinicalTrials.gov
• Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients#366586ClinicalTrials.gov
• Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer#366607ClinicalTrials.gov